Impact of Robotic Approach Compared to VATS and Open Approach on Quality of Life in Patients With Lung Cancer
NCT ID: NCT04353349
Last Updated: 2020-04-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
150 participants
OBSERVATIONAL
2016-04-01
2020-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multicenter Analysis of Different Approaches in Segmentectomies in Early-stage Lung Cancer
NCT06737107
Cost-effectiveness Evaluation of Robotic Surgery in the Removal of Lung Lesions in the ATS of Milan
NCT05674227
Retrospective Multi-Center Study to Compare Perioperative Outcomes for Robotic-assisted Lobectomy With Those Associated With VATS and Open Lobectomy for Lung Cancer
NCT03347825
Robot-assisted vs VATS Lobectomy for NSCLC
NCT03134534
Treatment of Early Stage Lung Cancer by VATS Versus OPEN Lobectomy
NCT01933828
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients operated with an open approach
No interventions assigned to this group
Patients operated with minimally invasive robotic approach
No interventions assigned to this group
Patients operated with VATS approach
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* N0-N1 candidates for surgery lobectomy or anatomical segmentectomy;
* ASA-1-2-3;
* not severe heart disease;
* no alcohol;
* no renal impairment (creatinine \<2);
* not obese (BMI \<30);
* no evidence of other serious comorbidities in the opinion of the investigator.
Exclusion Criteria
* renal impairment (creatinine \>2.5);
* evidence of any serious comorbidities according to the investigator;
* malignant tumor in the previous 2 years;
* previous chest surgery.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istituto Clinico Humanitas
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istituto Clinico Humanitas
Rozzano, Milan, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1524
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.